Effect of adjuvant EGFR-TKI therapy on the prognosis of pathological stage I invasive lung adenocarcinoma with sensitive EGFR mutations
- 5 September 2025
- journal article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 27 (2) , 177-188.e5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prevalence of EGFR Mutations in Patients With Resected Stages I to III NSCLC: Results From the EARLY-EGFR StudyJournal of Thoracic Oncology, 2024
- The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2024
- The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on stage I non–small cell lung cancer with sensitive EGFR mutationseClinicalMedicine, 2023
- Recurrence After Complete Resection for Non-Small Cell Lung Cancer in the National Lung Screening TrialThe Annals of Thoracic Surgery, 2023
- Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2–IA3 EGFR-Mutated NSCLC: ADAURA2Clinical Lung Cancer, 2023
- Adjuvant icotinib versus observation in patients with completely resected EGFR-mutated stage IB NSCLC (GASTO1003, CORIN): a randomised, open-label, phase 2 trialeClinicalMedicine, 2023
- Prevalence, clinical and molecular characteristics of early stage EGFR-mutated lung cancer in a real-life West-European cohort: Implications for adjuvant therapyEuropean Journal of Cancer, 2022
- Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapyAnnals of Oncology, 2021
- Distinct Prognostic Factors in Patients with Stage I Non–Small Cell Lung Cancer with Radiologic Part-Solid or Solid LesionsJournal of Thoracic Oncology, 2019
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2016